Genetic Disorder Cluster Muscular Dystrophy Drug Development Report 2 Genetic Disorder Cluster Muscular Dystrophy Drug D

Genetic Disorder Cluster Muscular Dystrophy
Drug Development Report 2017.
Summary
This report provides an overview of the genetic disorders pipeline landscape, specifically
focusing on muscular dystrophies.
The report provides comprehensive information on the therapeutics under development
and key players involved in therapeutic development for Becker and Duchene Muscular
Dystrophy (BMD and DMD) and features dormant and discontinued projects .
Both indications covered are inherited muscular dystrophies, a group of genetic,
degenerative diseases primarily affecting voluntary muscles.